JPS5495600A - Iminoobridged benzocycloheptapyridine - Google Patents

Iminoobridged benzocycloheptapyridine

Info

Publication number
JPS5495600A
JPS5495600A JP15427078A JP15427078A JPS5495600A JP S5495600 A JPS5495600 A JP S5495600A JP 15427078 A JP15427078 A JP 15427078A JP 15427078 A JP15427078 A JP 15427078A JP S5495600 A JPS5495600 A JP S5495600A
Authority
JP
Japan
Prior art keywords
iminoobridged
benzocycloheptapyridine
iminoobridged benzocycloheptapyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15427078A
Other languages
English (en)
Other versions
JPS6213957B2 (ja
Inventor
Eru Shiepaado Kenesu
Haruchienko Washiru
Jii Burennaa Danieru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5495600A publication Critical patent/JPS5495600A/ja
Publication of JPS6213957B2 publication Critical patent/JPS6213957B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP15427078A 1977-12-15 1978-12-15 Iminoobridged benzocycloheptapyridine Granted JPS5495600A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86066677A 1977-12-15 1977-12-15

Publications (2)

Publication Number Publication Date
JPS5495600A true JPS5495600A (en) 1979-07-28
JPS6213957B2 JPS6213957B2 (ja) 1987-03-30

Family

ID=25333744

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15427078A Granted JPS5495600A (en) 1977-12-15 1978-12-15 Iminoobridged benzocycloheptapyridine

Country Status (14)

Country Link
EP (1) EP0002512B1 (ja)
JP (1) JPS5495600A (ja)
AT (1) AT373256B (ja)
AU (1) AU4225778A (ja)
DE (1) DE2862381D1 (ja)
DK (1) DK561478A (ja)
ES (2) ES475977A1 (ja)
FI (1) FI783790A (ja)
GR (1) GR66834B (ja)
IE (1) IE48040B1 (ja)
IL (1) IL56112A0 (ja)
IT (1) IT1110891B (ja)
NO (1) NO784208L (ja)
PT (1) PT68882A (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252810A (en) * 1978-11-15 1981-02-24 Merck & Co., Inc. 9,10-Dihydro-4H-benzo[4,5]cyclohepta [1,2-b]thiophen-4,9-imines
JP2766266B2 (ja) * 1988-06-20 1998-06-18 協和醗酵工業株式会社 ピリジン誘導体およびその中間体
US5064831A (en) * 1990-09-14 1991-11-12 Bristol-Myers Squibb Co. Naphthothiophenimines for treating neuronal disorders caused by ischemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794904A (fr) * 1972-02-04 1973-08-02 Roussel Uclaf Nouveaux derives du dibenzocycloheptene et leur preparation

Also Published As

Publication number Publication date
IT7852319A0 (it) 1978-12-15
ES475977A1 (es) 1980-03-01
JPS6213957B2 (ja) 1987-03-30
DK561478A (da) 1979-07-31
NO784208L (no) 1979-06-18
DE2862381D1 (en) 1984-03-29
EP0002512A1 (en) 1979-06-27
ATA892078A (de) 1983-05-15
GR66834B (ja) 1981-05-04
IT1110891B (it) 1986-01-06
PT68882A (en) 1979-01-01
AT373256B (de) 1984-01-10
ES481207A1 (es) 1980-02-16
FI783790A (fi) 1979-06-16
IE782466L (en) 1979-06-15
AU4225778A (en) 1979-06-21
IE48040B1 (en) 1984-09-05
IL56112A0 (en) 1979-03-12
EP0002512B1 (en) 1984-02-22

Similar Documents

Publication Publication Date Title
CS343178A2 (en) Plynova turbina
AU4201478A (en) Step-stools
CS7801289A2 (en) Zpusob deleni smesi nukleovych kyselin
AU515984B2 (en) 4-substituted-pyrazoles
AU3526278A (en) L-sucrose
AU3728978A (en) Sulfamoyl-aryl-ketones
AU4022878A (en) Thiopropionamides
AU3828478A (en) Benzodiazepine-diones
AU3677378A (en) N-acylmethyl-chloroacetanilides
AU4286678A (en) 4a-aryl-octahydro-1h-2-pyrindines
CS541878A1 (en) Zpusob vyroby tricyklickych derivatu pyrimidinu
AU3918778A (en) Beta-substituted-diketones
AU3785078A (en) Piperidino-propanols
AU3939078A (en) 2-chlorosulfinylazetidin-4-ones
AU4216378A (en) Antibiotic-a-40104
AU4255778A (en) 3-di-n-propyl-acetoxy-benzodiazepin-2-ones
BG28612A1 (en) Auto- train
AU3774978A (en) Butyl-p-benzoylbenzoates
AU3939978A (en) 2-guanidinomethyl-indoline
AU3355078A (en) Aryl-hexafuranosides
AU4026278A (en) Thienobenzazepines
AU3533578A (en) Micro-mill-mixer
IL56112A0 (en) Imino-bridged benzocycloheptapyridines
AU3845478A (en) Isoquinoline-diones
AU520181B2 (en) Lkylthiophenoxypropanolamines